Radiant Innovation

Radiant Innovation Net Margin

The Net Profit Margin of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is -15.60 %. In the previous year, Net Profit Margin was -6.80 % — a change of 129.51% (lower).

Net Margin

-15.60 %

YoY

129.51%

Last updated:

Net Profit Margin of Radiant Innovation is 2025 -15.60 % . Net Profit Margin of Radiant Innovation was 2024 -6.80 % . It decreases by 129.51% lower compared to the previous year.

Radiant Innovation's net margin stands at -15.6%, down from 11.4% several years earlier.

The Radiant Innovation Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
1.75 TWD
Jan 1, 2019
3.66 TWD
Jan 1, 2020
28.14 TWD
Jan 1, 2021
11.42 TWD
Jan 1, 2022
5.08 TWD
Jan 1, 2023
-11.65 TWD
Jan 1, 2024
-6.80 TWD
Jan 1, 2025
-15.60 TWD
The Radiant Innovation Net Margin history
YEARNet MarginYoY
-15.60 %+129.51%
-6.80 %-41.68%
-11.65 %-329.51%
5.08 %-55.53%
11.42 %-59.43%
28.14 %+667.84%
3.66 %+109.95%
1.75 %+1.34%
1.72 %-60.80%
4.39 %-42.71%
7.67 %+56.72%
4.89 %+20,993.05%
0.02 %+136.16%
0.01 %-81.49%
0.05 %-33.65%
0.08 %-21.37%
0.10 %+29.26%
0.08 %-22.13%
0.10 %-20.32%
0.13 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Net Profit Margin of Radiant Innovation is -15.60 % in 2025.

Net Profit Margin of Radiant Innovation changed from -6.80 % to -15.60 %, representing a 129.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Radiant Innovation with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Radiant Innovation

All Key Metrics — Radiant Innovation